KMT2D and renal pelvis/ureter urothelial carcinoma: Therefore, we aimed to investigate KMT2D protein expression, mutation patterns, and prognostic value in UTUC patients using immunohistochemistry (IHC) and targeted next-generation sequencing (NGS).